» Articles » PMID: 17300291

Effect of Peripheral Obestatin on Gastric Emptying and Intestinal Contractility in Rodents

Overview
Date 2007 Feb 16
PMID 17300291
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Obestatin has recently been discovered in the rat stomach. It is encoded by the ghrelin gene and has been claimed to be a functional opponent of ghrelin and to be the natural ligand of the GPR39 receptor. The latter could not be confirmed by Holst et al. (Endocrinology, 2006). Yet, in GPR39 knockout mice, gastric emptying is accelerated. We verified the effects of obestatin on gastric emptying and intestinal contractility in rodents. Gastric emptying was measured with the (14)C octanoic breath test in mice. In vitro, the effect of obestatin was studied on electrically stimulated and non-stimulated strips from the fundus and small intestine of mice and rats. Obestatin (60, 125, 250 nmol kg(-1)) did not affect gastric emptying parameters (T(half) and T(lag)) and did not inhibit the prokinetic effects of ghrelin. Mouse and rat intestinal and fundic smooth muscle strips did not respond to obestatin either in the absence or in the presence of electrical field stimulation. Obestatin (125 nmol kg(-1)) did not inhibit fasting-induced hyperphagia. Our results suggest that peripheral obestatin is not a satiety signal that plays a role in the regulation of gastric emptying and do not support the concept that obestatin is a physiological opponent of ghrelin.

Citing Articles

Cardio-Protective Role of a Gut Hormone Obestatin: A Narrative Review.

Bora R, Prasad R, Khatib M Cureus. 2023; 15(4):e37972.

PMID: 37223200 PMC: 10202687. DOI: 10.7759/cureus.37972.


Diverse and Complementary Effects of Ghrelin and Obestatin.

Villarreal D, Pradhan G, Zhou Y, Xue B, Sun Y Biomolecules. 2022; 12(4).

PMID: 35454106 PMC: 9028691. DOI: 10.3390/biom12040517.


The effects of intra-stomach obestatin administration on intestinal contractility in neonatal piglets fed milk formula.

Slupecka-Ziemilska M, Szczurek P, Boryczka M, Gajewska M, Wychowanski P, Kuwahara A PLoS One. 2020; 15(3):e0230190.

PMID: 32203550 PMC: 7089538. DOI: 10.1371/journal.pone.0230190.


Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.

Kolodziejski P, Pruszynska-Oszmalek E, Strowski M, Nowak K Endocrine. 2017; 56(3):538-550.

PMID: 28477305 DOI: 10.1007/s12020-017-1309-2.


Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Cowan E, Burch K, Green B, Grieve D Br J Pharmacol. 2016; 173(14):2165-81.

PMID: 27111465 PMC: 4919582. DOI: 10.1111/bph.13502.